160TiP Safety and antitumor activity of GEN1042 in combination with pembrolizumab ± chemotherapy in solid tumors: Phase IIb dose-expansion trial in progress
- Resource Type
- Abstract
- Source
- In
Immuno-Oncology and Technology December 2023 20 Supplement - Subject
- Language
- ISSN
- 2590-0188